Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.

Liminal BioSciences Inc. LMNL

Liminal BioSciences is a biopharmaceutical company focused on the discovery and development of novel, small molecule drug candidates for the treatment of patients suffering from fibrotic or inflammatory diseases that have a high unmet medical need. Liminal BioSciences operates on an integrated basis from our talent hubs in Laval, Quebec, Canada, and Cambridge, UK. Our common shares are listed for trading on the Nasdaq Global Market.


NDAQ:LMNL - Post by User

Post by GoBBson May 05, 2020 12:55pm
112 Views
Post# 30988420

Go read the Managament Information Circular

Go read the Managament Information Circular
Posted to Sedar on Apr 30 ... and you will see as clear as the sky is blue what achieving nothing pays in compensation ... Every one of them all earn over 400K in just salaries with total compensation between 1 and 12Mil for Galbraith, 12 MILLION. Make your own conclusion what the game is here... this is money from the previous owners of PLI, from the poor saps that were suc ked into their rights offering AFTER repricing the company at nothing and taking ownership of it ... The courts should be opening soon.
<< Previous
Bullboard Posts
Next >>